How Multidisciplinary Care and Molecular Diagnostics Are Redefining Ocular Oncology
Miguel A. Materin, MD, discussed his new leadership role at Northwell Cancer Institute, and why a multidisciplinary approach is critical to managing ocular malignancies.
The management of ocular malignancies has historically straddled a fine line between ophthalmology and systemic oncology, occasionally falling into institutional silos that fragment patient care. With the recent appointment of ocular oncologist Miguel A. Materin, MD, to lead the adult and pediatric ocular oncology programs at Northwell Health, the institution is positioning itself to dismantle these barriers. By establishing an integrated network of medical oncologists, pediatric oncologists, radiation oncologists, pathologists, interventional neuroradiologists, and other oncology specialties, the program aims to streamline complex treatment pathways and improve outcomes for rare, high-stakes ocular cancers.